SEC Comment Letter 0000000000-25-001297 to Celularity Inc (CELU, CELUW) (CIK 0001752828) (CELU)
Celularity Inc (CELU, CELUW) (CIK 0001752828)
Date: Feb. 6, 2025 · CIK: 0001752828 · Accession: 0000000000-25-001297
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-284611
Letter
February 6, 2025 Robert Hariri Chief Executive Officer and Chairman of the Board of Directors Celularity Inc 170 Park Avenue Florham Park, New Jersey 07932 Re:Celularity Inc Registration Statement on Form S-1 Filed January 30, 2025 File No. 333-284611 Dear Robert Hariri: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tamika Sheppard at 202-551-8346 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
February 6, 2025
Robert Hariri
Chief Executive Officer and Chairman of the Board of Directors
Celularity Inc
170 Park Avenue
Florham Park, New Jersey 07932
Re:Celularity Inc
Registration Statement on Form S-1
Filed January 30, 2025
File No. 333-284611
Dear Robert Hariri:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tamika Sheppard at 202-551-8346 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences